USE OF CYSTEAMINE IN TREATING PARKINSON'S DISEASE

摘要

The subject invention provides materials and methods for treating neurodegenerative diseases. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat Parkinson's Disease and/or complications associated with Parkinson's Disease. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of Parkinson's Disease in an at-risk patient and/or treat or prevent the onset of Parkinson's Disease-associated symptoms.

主权项

1. A method for attenuating or treating Parkinson's Disease, wherein said method comprises diagnosing a patient with Parkinson's Disease; and administering to the patient an effective amount of a cysteamine compound or pharmaceutically acceptable salt thereof.